Literature DB >> 16925194

Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.

Steven F Solga1, Jeanne M Clark, Amir R Alkhuraishi, Michael Torbenson, Alireza Tabesh, Michael Schweitzer, Anna Mae Diehl, Thomas H Magnuson.   

Abstract

PURPOSE: Nonalcoholic fatty liver disease (NAFLD) is a common and potentially serious form of chronic liver disease. Although NAFLD is known to be associated with obesity and some comorbid conditions, less is known about the severity of NAFLD among different racial groups.
METHODS: We prospectively studied 237 consecutive morbidly obese patients presenting for bariatric surgery. All patients underwent intraoperative liver biopsy and chart review. After excluding subjects who reported alcohol use (n = 37) or who had missing biopsy data (n = 11), 189 patients were available for analysis. Clinical and laboratory associations with each of the histological components of NAFLD were assessed using multiple logistic regression analysis.
RESULTS: The mean age was 43.1 years, 84% were female, and 13% were African American. It was found that 88% had steatosis, including 35% with moderate to severe steatosis (> 33% of hepatocytes involved). Of these patients, 67% had inflammation, 46% had fibrosis, and 45% met Brunt's criteria for NASH. Compared with Caucasians and after adjustment, African Americans had significantly lower odds of severe hepatic pathology, with adjusted odds ratios of 0.1 (P = .02) for the presence of moderate or severe steatosis, 0.2 for inflammation (P = .006), 0.3 for fibrosis (P = .05), and 0.2 for NASH (P = .02). In addition, participants with one or more features of the metabolic syndrome (ie, diabetes, hypertension, or dyslipidemia) or elevated aminotransferase levels had significantly higher odds of severe hepatic histopathology.
CONCLUSION: Among obese patients presenting for bariatric surgery, NAFLD is more common in Caucasians, patients with features of the metabolic syndrome, and those with elevated aminotransferase levels.

Entities:  

Mesh:

Year:  2005        PMID: 16925194     DOI: 10.1016/j.soard.2004.12.006

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  16 in total

1.  Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.

Authors:  Eric R Kallwitz; Mrudula Kumar; Radhika Aggarwal; Reed Berger; Jennifer Layden-Almer; Neil Gupta; Scott J Cotler
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

2.  The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome.

Authors:  Lisa Krugner-Higby; Stephen Caldwell; Kathryn Coyle; Eugene Bush; Richard Atkinson; Valerie Joers
Journal:  Comp Med       Date:  2011-02       Impact factor: 0.982

3.  Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.

Authors:  Sahil Mittal; Yvonne H Sada; Hashem B El-Serag; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

4.  Effect of maternal high-fat diet on key components of the placental and hepatic endocannabinoid system.

Authors:  Kushal Gandhi; Cun Li; Nadezhda German; Cezary Skobowiat; Maira Carrillo; Raja Reddy Kallem; Eneko Larumbe; Stacy Martinez; Marcel Chuecos; Gary Ventolini; Peter Nathanielsz; Natalia Schlabritz-Loutsevitch
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-11-14       Impact factor: 4.310

5.  Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes.

Authors:  M G Browning; J Khoraki; J H DeAntonio; G Mazzini; M J Mangino; M S Siddiqui; L G Wolfe; G M Campos
Journal:  Int J Obes (Lond)       Date:  2017-12-21       Impact factor: 5.095

6.  Newly diagnosed diabetes mellitus as a risk factor for serious liver disease.

Authors:  Liane Porepa; Joel G Ray; Paula Sanchez-Romeu; Gillian L Booth
Journal:  CMAJ       Date:  2010-06-21       Impact factor: 8.262

7.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

8.  Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases.

Authors:  Christopher Kennedy; David Redden; Stephen Gray; Devin Eckhoff; Omar Massoud; Brendan McGuire; Basem Alkurdi; Joseph Bloomer; Derek A DuBay
Journal:  HPB (Oxford)       Date:  2012-06-14       Impact factor: 3.647

9.  Fatty acid and very low density lipoprotein metabolism in obese African American and Caucasian women with type 2 diabetes.

Authors:  Bernard V Miller; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  J Lipid Res       Date:  2012-10-09       Impact factor: 5.922

10.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.